A generic framework for making clinical decisions integrating diagnostic and therapeutic research evidence in preterm birth

Fetal and Maternal Medicine Review

Volumn 14, Issue 3, 2003, Pages 239-249

  Khan, Khalid S ^a   Honest, ^a   Bachmann, L M ^b  

^a BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; STEROID;

CERCLAGE; CLINICAL TRIAL; DIAGNOSTIC APPROACH ROUTE; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; MEDICAL DECISION MAKING; MEDICAL RESEARCH; NEWBORN; PREMATURE LABOR; PREMATURITY; RESPIRATORY DISTRESS SYNDROME; REVIEW; RISK ASSESSMENT; STEROID THERAPY; SYMPTOMATOLOGY; ULTRASOUND;

EID: 0242415320     PISSN: 09655395     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0965539503001104     Document Type: Review

References (40)

1. Nunn JF. The medical papyri. Ancient Egyptian Medicine London British Museum Press 1996; 24-41.
2. Honest H, Bachmann LM, Gupta JK, Kleijnen J, Khan KS. Accuracy of cervicovaginal fetal fibronectin test in predicting risk of spontaneous preterm birth: systematic review. Br Med J 2002; 325: 301.
3. Honest H, Bachmann LM, Gupta JK, Kleijnen J, Khan KS. Systematic quantitative overview of the literature to determine the accuracy of tests for predicting preterm birth. CRD Report 2003; in press.
4. Undertaking Systematic Reviews of Research on Effectiveness CRD's Guidance for those Carrying Out or Commissioning Reviews. CRD Report Number 4 (2nd Edition) 2001.
5. Maternal and Child Health Consortium. 6th Annual Report: Confidential Enquiries into Stillbirths and Deaths in Infancy (CESDI). 1999.
6. Peters KD, Kochanek KD, Murphy SL. Deaths: final data for 1996. Natl Vital Stat Rep 1998; 47: 1-100.
7. Paneth NS. The problem of low birth weight. Future Child 1995; 5: 19-34.
8. Stewart AL, Rifkin L, Amess PN, Kirkbride V, Townsend JP, Miller DH et al. Brain structure and neurocognitive and behavioural function in adolescents who were born very preterm. Lancet 1999; 353: 1653-657.
9. Wolke D, Meyer R. Cognitive status, language attainment, and prereading skills of 6-year-old very preterm children and their peers: the Bavarian Longitudinal Study. Dev Med Child Neurol 1999; 41: 94-109.
10. Seubert DE, Stetzer BP, Wolfe HM, Treadwell MC. Delivery of the marginally preterm infant: what are the minor morbidities? Am J Obstet Gynecol 1999; 181: 1087-1091.
11. Bachmann LM, Coomarasamy A, Honest H, Khan KS. Cervical cerclage for prevention of preterm birth: A meta-analysis. Acta Obstet Gynecol Scand 2003; 81: 1-7.
12. Crowley P. Prophylactic corticosteroids for preterm birth. Cochrane Database Syst Rev 2000; (2): CD000065.
13. Smith GD, Egger M. Who benefits from medical interventions? Br Med J 1994; 308: 72-74.
14. Glasziou PP, Irwig LM. An evidence based approach to individualising treatment. Br Med J 1995; 311: 1356-359.
15. Guyatt GH, Sackett DL, Sinclair JC, Hayward R, Cook DJ, Cook RJ. Users' guides to the medical literature. IX. A method for grading health care recommendations. Evidence-Based Medicine Working Group. JAMA 1995; 274: 1800-804.
16. Khan KS, Chien PF. Seizure prophylaxis in hypertensive pregnancies: a framework for making clinical decisions. Br J Obstet Gynaecol 1997; 104: 1173-179.
17. Sinclair JC, Cook RJ, Guyatt GH, Pauker SG, Cook DJ. When should an effective treatment be used? Derivation of the threshold number needed to treat and the minimum event rate for treatment. J Clin Epidemiol 2001; 54: 253-62.
18. Drummond M, O'Brien B, Stoddard G, Torrance G. Methods for the economic evaluation of health care programmes. 2nd. Oxford. Oxford University Press 1997.
19. Kunz R, Neumayer HH, Khan KS. When small degrees of bias in randomized trials can mislead clinical decisions: an example of individualizing preventive treatment of upper gastrointestinal bleeding. Crit Care Med 2002; 30: 1503-507.
20. Cook RJ, Sackett DL. The number needed to treat: a clinically useful measure of treatment effect. Br Med J 1995; 310: 452-54.
21. Kristiansen IS, Gyrd-Hansen D, Nexoe J, Nielsen JB. Number needed to treat: easily understood and intuitively meaningful? Theoretical considerations and a randomized trial. J Clin Epidemiol 2002; 55: 888-92.
22. Laupacis A, Sackett DL, Roberts RS. An assessment of clinically useful measures of the consequences of treatment. N Engl J Med 1988; 318: 1728-733.
23. Cochrane Methods Group on Systematic Review of Screening and Diagnostic Tests: Recommended Methods, last updated on 9 February 1998. Available at http://www.cochrane.org/cochrane/ sadtdocl.htm. 1996.
24. Deeks JJ. Systematic reviews of evaluation of diagnostic and screening tests. In: Egger M, Davey Smith G, Altman DG, editors. Systematic Reviews in Health Care Meta-analysis in context. BMJ Publishing Group, 2001: 248-82.
25. Deville WL, Buntinx F, Bouter LM, Montori VM, De Vet HC, Van Der Windt DA et al. Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol 2002; 2: 9.
26. Honest H, Khan KS. Systematic reviews of test accuracy studies in reporductive health. WHO Reproductive Health Library (No 5), Geneva, WHO/RHR 2002.
27. Khan KS, ter Riet G, Popay J, Nixon J, Kleijnen J. Study quality assessment (phase 5): Conducting the review (stage II). In: CRD report no. 4. Undertaking systematic reviews of research on effectiveness. 2001; 1-20. Last updated 2001 Available at http://www.york.ac.uk/inst/crd/report4.htm.
28. Khan KS, Dinnes J, Kleijnen J. Systematic reviews to evaluate diagnostic tests. Eur J Obstet Gynecol Reprod Biol 2001; 95: 6-11.
29. Honest H, Bachmann LM, Coomarasamy A, Gupta JK, Kleijnen J, Khan KS. Accuracy of endovaginal ultrasonographic cervical length measurement in predicting the risk of spontaneous preterm birth - A systematic review. Br J Obstet Gynaecol 2002; submitted.
30. Ioannidis JP, Lau J. Heterogeneity of the baseline risk within patient populations of clinical trials: a proposed evaluation algorithm. Am J Epidemiol 1998; 148: 1117-126.
31. Schmid CH, Lau J, McIntosh MW, Cappelleri JC. An empirical study of the effect of the control rate as a predictor of treatment efficacy in meta-analysis of clinical trials. Stat Med 1998; 17: 1923-942.
32. Furukawa TA, Guyatt GH, Griffith LE. Can we individualize the 'number needed to treat'? An empirical study of summary effect measures in meta-analyses. Int J Epidemiol 2002; 31: 72-76.
33. Cates CJ. Simpson's paradox and calculation of number needed to treat from meta-analysis. BMC Med Res Methodol 2002; 2: 1.
34. Guyatt GH, Tugwell PX, Feeny DH, Haynes RB, Drummond M. A framework for clinical evaluation of diagnostic technologies. CMAJ 1986; 134: 587-94.
35. Chien PF, Khan KS. Evaluation of a clinical test. II: Assessment of validity. Br J Obstet Gynaecol 2001; 108: 568-72.
36. Fryback DG, Thornbury JR. The efficacy of diagnostic imaging. Medical Decision Making 1991; 11: 88-94.
37. Khan KS, Chien PF. Evaluation of a clinical test. I: assessment of reliability. Br J Obstet Gynaecol 2001; 108: 562-67.
38. Khan KS, Khan SF, Nwosu CR, Arnott N, Chien PF. Misleading authors' inferences in obstetric diagnostic test literature. Am J Obstet Gynecol 1999; 181: 112-15.
39. Hoffrage U, Lindsey S, Hertwig R, Gigerenzer G. Medicine. Communicating statistical information. Science 2000; 290: 2261-262.
40. Steurer J, Fischer JE, Bachmann LM, Koller M, ter Riet G. Communicating accuracy of tests to general practitioners: a controlled study. Br Med J 2002; 394: 824-26.